Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR

Delayed Quote. Delayed  - 07/27 10:00:00 pm
26.71 USD   +3.09%
07/07 ACORDA THERAPEU : to Host Conference Call to Discuss Second Quarter ..
07/05 ACORDA THERAPEU : Appoints Burkhard Blank, M.D., as Chief Medical Of..
07/02 ACORDA THERAPEU : Names New Chief Medical Officer
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2016 07/22/2016 07/25/2016 07/26/2016 07/27/2016 Date
25.41(c) 25.6(c) 26.05(c) 25.91(c) 26.71(c) Last
373 902 302 788 301 861 231 806 502 704 Volume
-2.19% +0.75% +1.76% -0.54% +3.09% Change
More quotes
Financials ($)
Sales 2016 516 M
EBIT 2016 6,63 M
Net income 2016 -6,42 M
Debt 2016 81,2 M
Yield 2016 -
Sales 2017 561 M
EBIT 2017 48,5 M
Net income 2017 -2,26 M
Debt 2017 97,1 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 2,47x
EV / Sales2017 2,30x
Capitalization 1 194 M
More Financials
Company
Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders.The company's two main products are Ampyra and Zanaflex Capsules.The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
07/14 ACORDA THERAPEUTICS : Appoints Burkhard Blank, M.D., as Chief Medical Officer CM..
07/07 ACORDA THERAPEUTICS : to Host Conference Call to Discuss Second Quarter 2016 on ..
07/05 ACORDA THERAPEUTICS : Appoints Burkhard Blank, M.D., as Chief Medical Officer (C..
07/02 ACORDA THERAPEUTICS : Names New Chief Medical Officer
07/02 ACORDA THERAPEUTICS : Appoints Burkhard Blank, M.D., as Chief Medical Officer
07/01 ACORDA THERAPEUTICS INC : Other Events, Financial Statements and Exhibits (form ..
07/01 ACORDA THERAPEUTICS : Appoints Burkhard Blank, M.D., as Chief Medical Officer (C..
07/01 ACORDA THERAPEUTICS : Appoints Burkhard Blank, M.D., as Chief Medical Officer (C..
06/27 ACORDA THERAPEUTICS : Completion of Acquisition or Disposition of Assets, Financ..
06/21 ACORDA THERAPEUTICS INC : Other Events (form 8-K)
More news
Sector news : Bio Therapeutic Drugs
07/27DJVERTEX PHARMACEUTICALS : Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
07/27DJAMGEN : Profit Rises 13%, 2016 Outlook Raised
07/27DJAMGEN : Profit Rises 13%, 2016 Outlook Raised -- Update
07/27DJAmgen Profit Rises 13%, 2016 Outlook Raised
07/27 GSK chases next biotech asthma drug with 175 million pounds J&J deal
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
07/27 Notable earnings before Thursday?s open
07/07 Acorda Therapeutics Has Significant Upside From Its Current Stock Price
06/30 Biotine announces changes in management team
05/23 BIOTECH FORUM DAILY DIGEST : Can Biotech Rally For The Second Week In A Row? New..
05/20 Acorda bags development of PLUMIAZ for epilepsy seizures after lagging Diasta..
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends ACORDA THERAPEUTI...
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Average target price 39,9 $
Spread / Average Target 54%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Ronald Cohen President, Chief Executive Officer & Director
David Lawrence Head-Business Operations
Michael W. Rogers Chief Financial Officer
Andrew R. Blight Chief Scientific Officer
Anthony O. Caggiano Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ACORDA THERAPEUTICS IN..-39.43%1 194
AMGEN, INC.3.29%125 957
GILEAD SCIENCES, INC.-19.90%107 944
CELGENE CORPORATION-11.34%82 247
REGENERON PHARMACEUTIC..-27.26%41 850
VERTEX PHARMACEUTICALS..-24.52%23 493
More Results